Full name
CENTRUM BADAWCZO-ROZWOJOWE "NOVASOME" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Scientific research and development activities
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
71.20 - Technical testing and analysis
72.11.Z - Scientific research and development activities
77.39.Z - Rental and leasing of other machinery, equipment, and tangible assets, not elsewhere classified
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.22.Z - Specialist medical practice
86.90.C - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,2 | 0,7 | 2,4 | 230,8 |
EBITDA | 1,5 | 2 | 3,9 | 98,6 |
Short time liabilities | 3,6 | 3,1 | 1,3 | -56,7 |
Equity capital | 17,3 | 18,1 | 20,5 | 13,5 |
Operating profit (EBIT) | 0,3 | 0,9 | 2,8 | 223,8 |
Assets | 22,5 | 24,3 | 26 | 7,1 |
Net profit (loss) | 0,2 | 0,7 | 2,4 | 230,8 |
Cash | 8,1 | 7,3 | 2,8 | -62,3 |
Net income from sale | 7,1 | 8,4 | 10,2 | 22 |
Liabilities and provisions for liabilities | 5,1 | 6,2 | 5,5 | -11,6 |
Working assets | 13,6 | 14,1 | 13 | -7,6 |
Depreciation | 1,2 | 1,1 | 1,2 | 4,2 |
% | % | % | p.p. | |
Profitability of capital | 1 | 4,1 | 11,9 | 7,8 |
Equity capital to total assets | 77,3 | 74,5 | 78,9 | 4,4 |
Gross profit margin | 2,5 | 8,8 | 23,8 | 15 |
EBITDA Margin | 21 | 23,6 | 38,4 | 14,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 186 | 135 | 48 | -87 |
Current financial liquidity indicator | 2.6651060581207275 | 2.993710994720459 | 2.8166511058807373 | -0,2 |
Net dept to EBITDA | -3.8150689601898193 | -1.767578125 | -0.26495587825775146 | 1,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane